GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling

Trends in Endocrinology and Metabolism

Volumn 17, Issue 4, 2006, Pages 159-165

  Reiter, Eric ^a,b   Lefkowitz, Robert J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE H1 RECEPTOR; I KAPPA B; SMALL INTERFERING RNA;

BINDING AFFINITY; CELL FUNCTION; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 33646162635     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2006.03.008     Document Type: Review

References (69)

1. Takeda S., et al. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett. 520 (2002) 97-101
2. Pierce K.L., et al. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
3. Brink C.B., et al. Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br. J. Clin. Pharmacol. 57 (2004) 373-387
4. Bockaert J., et al. GPCR interacting proteins (GIP). Pharmacol. Ther. 103 (2004) 203-221
5. Lefkowitz R.J., and Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 308 (2005) 512-517
6. Pitcher J.A., et al. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67 (1998) 653-692
7. Shenoy S.K., and Lefkowitz R.J. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 375 (2003) 503-515
8. Freedman N.J., and Lefkowitz R.J. Desensitization of G protein-coupled receptors. Recent Prog. Horm. Res. 51 (1996) 319-351
9. Liggett S.B., et al. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 3665-3669
10. Perry S.J., et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298 (2002) 834-836
11. Kim J., et al. Functional antagonism of different G protein-coupled receptor kinases for {beta}-arrestin-mediated angiotensin II receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1442-1447
12. Ren X.R., et al. Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1448-1453
13. Iwata K., et al. Bimodal regulation of the human H1 histamine receptor by G protein-coupled receptor kinase 2. J. Biol. Chem. 280 (2005) 2197-2204
14. Gainetdinov R.R., et al. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24 (1999) 1029-1036
15. Gainetdinov R.R., et al. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38 (2003) 291-303
16. Tiberi M., et al. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 271 (1996) 3771-3778
17. Aiyar N., et al. Involvement of G protein-coupled receptor kinase-6 in desensitization of CGRP receptors. Eur. J. Pharmacol. 403 (2000) 1-7
18. Willets J.M., et al. Endogenous G protein-coupled receptor kinase 6 regulates M3 muscarinic acetylcholine receptor phosphorylation and desensitization in human SH-SY5Y neuroblastoma cells. J. Biol. Chem. 277 (2002) 15523-15529
19. Oakley R.H., et al. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J. Biol. Chem. 276 (2001) 19452-19460
20. Oakley R.H., et al. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275 (2000) 17201-17210
21. Ahn S., et al. Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1740-1744
22. Ahn S., et al. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J. Biol. Chem. 279 (2004) 7807-7811
23. Marchese A., et al. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem. Sci. 28 (2003) 369-376
24. Lefkowitz R.J., et al. Mechanisms of beta-adrenergic receptor desensitization and resensitization. Adv. Pharmacol. 42 (1998) 416-420
25. Claing A., et al. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog. Neurobiol. 66 (2002) 61-79
26. Goodman Jr. O.B., et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383 (1996) 447-450
27. Laporte S.A., et al. The β2-adrenergic receptor/β-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3712-3717
28. Claing A., et al. β-Arrestin-mediated ADP-ribosylation factor 6 activation and β2-adrenergic receptor endocytosis. J. Biol. Chem. 276 (2001) 42509-42513
29. McDonald P.H., et al. Identification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation. J. Biol. Chem. 274 (1999) 10677-10680
30. Naga Prasad S.V., et al. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J. Cell Biol. 158 (2002) 563-575
31. Naga Prasad S.V., et al. Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat. Cell Biol. 7 (2005) 785-796
32. Shenoy S.K., et al. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294 (2001) 1307-1313
33. Shenoy S.K., and Lefkowitz R.J. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278 (2003) 14498-14506
34. Lefkowitz R.J., and Whalen E.J. beta-arrestins: traffic cops of cell signaling. Curr. Opin. Cell Biol. 16 (2004) 162-168
35. Luttrell L.M., et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283 (1999) 655-661
36. DeFea K.A., et al. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11086-11091
37. Barlic J., et al. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat. Immunol. 1 (2000) 227-233
38. Imamura T., et al. β-Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J. Biol. Chem. 276 (2001) 43663-43667
39. McDonald P.H., et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290 (2000) 1574-1577
40. DeFea K.A., et al. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148 (2000) 1267-1281
41. Luttrell L.M., et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2449-2454
42. Sun Y., et al. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277 (2002) 49212-49219
43. Miller W.E., et al. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. J. Biol. Chem. 278 (2003) 21663-21671
44. Witherow D.S., et al. beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8603-8607
45. Gao H., et al. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14 (2004) 303-317
46. Beaulieu J.M., et al. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122 (2005) 261-273
47. Barnes W.G., et al. β-Arrestin 1 and Gαq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J. Biol. Chem. 280 (2005) 8041-8050
48. Kohout T.A., et al. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J. Biol. Chem. 279 (2004) 23214-23222
49. Fong A.M., et al. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7478-7483
50. Wei H., et al. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10782-10787
51. Ahn S., et al. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem. 279 (2004) 35518-35525
52. Shenoy S.K., et al. β-Arrestin-dependent, G protein-independent ERK1/2 activation by the beta 2 adrenergic receptor. J. Biol. Chem. 281 (2005) 1261-1273
53. Ge L., et al. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J. Biol. Chem. 278 (2003) 34418-34426
54. Gesty-Palmer, D. et al. (2006) Distinct beta-arrestin and G protein dependent pathways for parathyroid hormone receptor stimulated ERK1/2 activation. J Biol Chem (in press)
55. Storez H., et al. Homo- and hetero-oligomerization of β-arrestins in living cells. J. Biol. Chem. 280 (2005) 40210-40215
56. Xiao K., et al. Activation-dependent conformational changes in β-arrestin 2. J. Biol. Chem. 279 (2004) 55744-55753
57. Penela P., et al. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell. Signal. 15 (2003) 973-981
58. Lorenz K., et al. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426 (2003) 574-579
59. Liu S., et al. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat. Med. 11 (2005) 952-958
60. Jimenez-Sainz M.C., et al. G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits. Mol. Biol. Cell 17 (2006) 25-31
61. Hunton D.L., et al. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol. Pharmacol. 67 (2005) 1229-1236
62. Ge L., et al. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J. Biol. Chem. 279 (2004) 55419-55424
63. Walker J.K., et al. Beta-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112 (2003) 566-574
64. Revankar C.M., et al. Arrestins block G protein-coupled receptor-mediated apoptosis. J. Biol. Chem. 279 (2004) 24578-24584
65. Kang J., et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123 (2005) 833-847
66. Brzostowski J.A., and Kimmel A.R. Signaling at zero G: G-protein-independent functions for 7-TM receptors. Trends Biochem. Sci. 26 (2001) 291-297
67. Kenakin T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J. 15 (2001) 598-611
68. Azzi M., et al. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11406-11411
69. Maudsley S., et al. The origins of diversity and specificity in G protein-coupled receptor signaling. J. Pharmacol. Exp. Ther. 314 (2005) 485-494